Mark Heinen Better Therapeutics, Inc. (BTTX) insider trading activity
Mark Heinen is Chief Financial Officer of Better Therapeutics, Inc.. Currently has a direct ownership of 139,723 shares of BTTX, which is worth approximately $0. The most recent transaction as insider was on Apr 05, 2023, when has been sold 54,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
140K
0%
3M change
0%
12M change
Total Value Held
$0
Mark Heinen Transaction History
Also insider at
MH
Mark Heinen
Chief Financial Officer
San Francisco, CA